The particle size of a vaccine has a considerable influence on its half-life in vivo, as well as on
its uptake by antigen-presenting cells.
Here we use the Litesizer to characterize the particle size and the zeta potential of vaccines against COVID-19, tick-borne encephalitis and influenza.
Download this report now to find out more.
Please contact us at info.gb@anton-paar.com or visit our website for further information.
Anton Paar Ltd
Tel: +44(0)1992514730
info.gb@anton-paar.com
www.anton-paar.co.uk
Click here and register to access technical articles and white papers from this company
Comment: Hydrogen requires a long-term mindset
Hydrogen does have and will have its uses. There are always "nay sayers" but these should not be confused with those raising issues that...